Suppr超能文献

慢性完全闭塞病变经皮治疗中对比剂肾病的评估

Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions.

作者信息

Aktürk Erdal, Aşkın Lütfü, Taşolar Hakan, Kurtoğlu Ertuğrul, Türkmen Serdar, Tanrıverdi Okan, Uzel Kader Eliz

机构信息

Faculty of Medicine, Department of Cardiology, Adiyaman University, Adiyaman, Turkey.

Faculty of Medicine, Department of Cardiology, Inönü University, Malatya, Turkey.

出版信息

Interv Med Appl Sci. 2019 Jun;11(2):95-100. doi: 10.1556/1646.11.2019.15.

Abstract

BACKGROUND

Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography.

METHODS

A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg · h saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg · h only during CTO-PCI procedure, which is called as intensive infusion.

RESULTS

CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375;  < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN.

CONCLUSION

Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure.

摘要

背景

对比剂肾病(CIN)是接受经皮冠状动脉介入治疗(PCI)患者发病和死亡的主要原因。在接受冠状动脉造影的患者中经常观察到慢性完全闭塞(CTO)。

方法

共纳入128例CTO患者。记录梅兰评分、病变特征、介入操作、血清学标本和器械。第一组按照指南建议,在手术前12小时开始以1 ml·kg·h的速度输注生理盐水(0.9%氯化钠),并在术后持续12小时。第二组仅在CTO-PCI手术期间以12 ml·kg·h的速度输注生理盐水,即强化输注。

结果

两组CIN的发生情况相似(标准水化组4例,强化水化组5例)。标准组的生理盐水用量明显更高(1767±192.2 vs. 1043.6±375;<0.001)。PCI术前肌酐水平较高的患者术后发生CIN的几率更高。有趣的是,年龄、左心室射血分数和糖尿病独立预测CIN。

结论

强化水化给药似乎是CTO-PCI患者一种有效且经济高效的方法,尤其是在没有左心室功能衰竭的患者中。

相似文献

本文引用的文献

6
Contrast-induced Nephropathy.对比剂肾病
Heart Views. 2013 Jul;14(3):106-16. doi: 10.4103/1995-705X.125926.
10
Contrast-induced nephropathy in invasive cardiology.介入心脏病学中的对比剂肾病。
Swiss Med Wkly. 2012 Jun 19;142:w13608. doi: 10.4414/smw.2012.13608. eCollection 2012.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验